Yarrow Bioscience annual capital expenditures (capex)
2015
2016
2017
2018
2019
2020
2021
2023
2024
2025
Yarrow Bioscience Capital Expenditures (CapEx) Growth & History (YARW)
Yarrow Bioscience's capital expenditures (capex) was $0 for fiscal 2025.
View full Yarrow Bioscience company overviewYarrow Bioscience annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$117,000 | — |
| 2024 | 2024-12-31 | $117,000 | $117,000 | — |
| 2023 | 2023-12-31 | $0 | — | — |
| 2021 | 2021-12-31 | $0 | −$113,000 | — |
| 2020 | 2020-12-31 | $113,000 | −$945,000 | −89.32% |
| 2019 | 2019-12-31 | $1.1M | $491,000 | +86.60% |
| 2018 | 2018-12-31 | $567,000 | $540,000 | +2000.00% |
| 2017 | 2017-12-31 | $27,000 | −$4,000 | −12.90% |
| 2016 | 2016-12-31 | $31,000 | $31,000 | — |
| 2015 | 2015-12-31 | $0 | — | — |
Yarrow Bioscience quarterly capital expenditures (capex)
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2021 | 2021-12-31 | $0 | $0 | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $0 | −$71,000 | — |
| Q1 2021 | 2021-03-31 | $0 | −$42,000 | — |
| Q4 2020 | 2020-12-31 | $0 | −$197,000 | — |
| Q3 2020 | 2020-09-30 | $0 | −$407,000 | — |
| Q2 2020 | 2020-06-30 | $71,000 | −$245,000 | −77.53% |
| Q1 2020 | 2020-03-31 | $42,000 | −$96,000 | −69.57% |
| Q4 2019 | 2019-12-31 | $197,000 | — | — |
| Q3 2019 | 2019-09-30 | $407,000 | — | — |
| Q2 2019 | 2019-06-30 | $316,000 | — | — |
| Q1 2019 | 2019-03-31 | $138,000 | — | — |
Yarrow Bioscience capital expenditures (capex) trends
Over the last five fiscal years, Yarrow Bioscience's capital expenditures (capex) decreased from $113,000 to $0, a change of −$113,000. The latest reported quarter, Q4 2021, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yarrow Bioscience source filings ↗